adding dexmedetomidine to intrathecal low dose bupivacaine in vaginal hysterectomy

41
ADDING DEXMEDETOMIDINE TO INTRATHECAL LOW DOSE BUPIVACAINE IN VAGINAL HYSTERECTOMY CO-AUTHORS PROF & HEAD .DR. I.CHANDRASEKARAN MD ,DA PROF .DR.S.P.MEENAKSHISUNDARAM MD,DA ASST. PROF . DR.S.SENTHILKUMAR MD.,DA. AUTHOR DR.T.ARUNPRAKASH INSTITUTE OF ANESTHESIOLOGY MMC , MADURAI

Upload: sheila-zimmerman

Post on 14-Mar-2016

52 views

Category:

Documents


2 download

DESCRIPTION

ADDING DEXMEDETOMIDINE TO INTRATHECAL LOW DOSE BUPIVACAINE IN VAGINAL HYSTERECTOMY. CO-AUTHORS PROF & HEAD .DR. I.CHANDRASEKARAN MD ,DA PROF .DR.S.P.MEENAKSHISUNDARAM MD,DA ASST. PROF . DR.S.SENTHILKUMAR MD.,DA. AUTHOR DR.T.ARUNPRAKASH - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

ADDING DEXMEDETOMIDINE TO INTRATHECAL LOW DOSE

BUPIVACAINE IN VAGINAL HYSTERECTOMY

CO-AUTHORSPROF & HEAD .DR. I.CHANDRASEKARAN MD ,DA

PROF .DR.S.P.MEENAKSHISUNDARAM MD,DAASST. PROF . DR.S.SENTHILKUMAR MD.,DA.

AUTHOR DR.T.ARUNPRAKASH INSTITUTE OF ANESTHESIOLOGY

MMC , MADURAI

Page 2: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

AIM

• To study the effect of adding dexmeditomedine with intrathecal low dose bupivacaine for vaginal hysterectomy on

• sensory and motor blockade

• Postoperative analgesia

Page 3: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

STUDY DESIGN• Randomised double blind control study • 60 patients , 30 in each group

• Inclusions• ASA I & II • Age 30 to 60 yrs• Vaginal hysterectomy • BMI 18.5 to 25

• Exclusions• Contraindications to spinal anesthesia• Allergy to local anesthetics

Page 4: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

METHODS • Patients were divided into two groups

• B – inj 0.5 % hyperbaric bupivacaine 2cc

+0.05ml of NS

• BD – inj 0.5 % hyperbaric bupivacaine 2cc +

0.05 ml of dexmedetomidine (5μg)

Page 5: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

• 18G iv cannula secured

• Monitors

• Patient in right lateral position

• Under strict aseptic precautions , SAB performed with 25G Quincke spinal needle in the L3- L4 interspace

Page 6: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

OBSERVATIONS

• Onset of sensory block to pin prick• Onset of motor block ( bromage score)• Time for two segment regression • Sensory recovery time to pin prick •Motor recovery time( bromage score)

Page 7: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

• PR if less than 60/min inj atropine 0.6 mg iv given

• BP if MAP less than 70 mmHg inj ephedrine iv given in titrated doses

• SPO2

• RR • SEDATION by Ramsay Score

Page 8: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

BROMAGE SCORE FOR MOTOR BLOCKADE

Grade Criteria

I Free movement of hips, legs and feet

II Just able to flex knees with free movement of feet

III Unable to flex knees, but with free movement of feet

IV Unable to move hips or legs or feet

Page 9: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

RAMSAY SEDATION SCORE

1- Patient anxious and agitated or restless2- Patient co-operative, oriented, and tranquil3- Patient responds to commands only4- Patient exhibits brisk response to light glabellar tap or loud

auditory stimulus5- Patient exhibits a sluggish response to light glabellar tap or

loud auditory stimulus6- Patient exhibits no response

Page 10: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

• Postop analgesia assessed by VAS score• If VAS > 4 –study completed,inj diclofenac 75

mg IM given • Side effects

• Hypotension • Bradycardia• Nausea , vomiting • Pruritus

Page 11: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

ANALYSIS

• Demographic datas• Onset of sensory and motor blockade• Maximum level of sensory blockade• Offset time of sensory and motor blockade• Duration of post op analgesia• Side effects

Page 12: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

STATISTICAL ANALYSIS

Chi-square test

If p < 0.05 is significant

Page 13: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

DEMOGRAPHIC DATA

VARIABLE BD GROUP

(n = 30)

B GROUP

(n = 30)

“p”

Age in years 48.9 + 8.5 49.2 + 7.4 0.8411

(> 0.05)

Weight (in kgs) 48.9 + 5.3 48.5 + 4.6 0.6284

(>0.05)

Height ( in cms) 143.1 + 3.8 143 + 3.5 0.9109

(>0.05)

BMI 23.9 + 2.76 23.8 + 2.64 0.579

(>0.05)

Page 14: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

AGE & BMI

Page 15: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

ASA

BD GROUP n = 30

B GROUP n = 30

ASA p = 1.000 (>0.05)

Page 16: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

ASA

Page 17: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

ONSET OF SENSORY BLOCK

Onset of sensory blockade (min)

BD GROUP (n = 30)

B GROUP

(n = 30)

Mean 2± 0.74 4.67± 0.66

p = 0.0001 ( < 0.05 )

Page 18: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

ONSET OF SENSORY BLOCK( MIN)

Page 19: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

ONSET OF MOTOR BLOCK

Onset of motor blockade (min)

BD GROUP (n = 30)

B GROUP

(n = 30)

Mean 5.53± 2.42 8.07± 0.64

p = 0.0001 ( < 0.05 )

Page 20: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

ONSET OF MOTOR BLOCK(MIN)

Page 21: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

MAXIMUM SENSORY LEVEL

Maxmimum sensory level

BD GROUP (n = 30)

B GROUP (n = 30)

NO. % NO. %

T6 2 6.7 - - T7 5 16.7 - -

T8 19 63.3 17 56.7 T9 4 13.3 10 33.3 T10 - - 3 10

Page 22: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

MAXMIMUM SENSORY LEVEL

Page 23: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

TIME FOR 2 SEGMENT REGRESSION

Time for two segment regression (min)

BD GROUP n = 30

B GROUP

n =30

Mean

115.3± 7.6 100.6 ± 6.2

p = 0.0001 ( < 0.05 )

Page 24: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

TIME FOR 2 SEGMENT REGRESSION(MIN)

Page 25: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

SENSORY RECOVERY TIME TO S1

Sensory recovery time to S1 (min)

BD GROUP n = 30

B GROUP n = 30

Mean 292.8± 19.4 173.7± 9.3

p = 0.0001 ( < 0.05 )

Page 26: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

SENSORY RECOVERY TIME TO S1( MIN)

Page 27: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

MOTOR RECOVERY TIME

Motor recovery time (min)

BD GROUP (n = 30)

B GROUP

(n = 30)

Mean 121.1± 7 88.4 ± 6

p = 0.0001 ( < 0.05 )

Page 28: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

MOTOR RECOVERY TIME (MIN)

Page 29: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

MAP AT VARIOUS TIME INTERVALS

Mean arterial pressure (mmHg) at

BD GROUP (n = 30)

B GROUP (n = 30)

0 minute 90.9 + 4.1 90.2 + 4.3

5 minutes 88.7 + 3.6 88.2 + 4.1

10 minutes 85.5 + 4.0 86.6 + 4.2

15 minutes 80.7 + 3.9 82.9 + 5.2

30 minutes 76.9 + 4.9 80.1 + 6.2

1 hour 73.3 + 6 77.7 + 8.3

2 hours 78.5 + 4.7 81.1 + 7.0

3 hours 81.7 + 4.6 83.3 + 5.7

4 hours 85.1 + 3.9 87 + 4.0

5 hours 88.5 + 3.5 88.5 + 3.6

Page 30: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

MEAN ARTERIAL PRESSURE

60

70

80

90

100

0 min. 5 min. 10 min.

15 min.

30 min.

1 hour 2 hrs 3 hrs 4 hrs 5 hrs

Chart Title

DEXMEDITOMEDINE GROUP CONTROL GROUP

Page 31: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

PULSE RATE AT VARIOUS TIME INTERVALS

Mean pulse rate at BD GROUP (n = 30)

B GROUP (n = 30)

0 minute 86.2 + 9.4 81.1 + 9.3

5 minutes 84.4 + 7.3 81.4 + 6.0

10 minutes 81.7 + 7.2 79.2 + 5.1

15 minutes 78.6 + 5.8 77.1 + 4.8

30 minutes 74.7 + 6.7 73.9 + 5.9

1 hour 70.1 + 6.2 73.1 + 6.3

2 hours 75.2 + 4.8 76.5 + 5.0

3 hours 78.9 + 4.4 77.3 + 4.3

4 hours 83 + 4.0 80.6 + 6.0

5 hours 85 + 5.2 83.3 + 5.4

Page 32: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

PULSE RATE

Page 33: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

SEDATION SCORE

Sedation score BD GROUP (n = 30)

B GROUP (n = 30)

Mean 2.39 ± 0.20 1.00

p = 0.0001 ( < 0.05 )

Page 34: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

SEDATION SCORE

Page 35: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

OBSERVATION

Statistical analysis between BD and B GROUP shown that

GROUP BD patients have• Early Sensory and motor onset time• delayed Two segment regression• Motor recovery time• prolonged post op analgesia• Good sedation

Than GROUP B patients

Page 36: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

DEXEMEDETOMIDINE IN SPINAL

Intrathecal α2-agonists

Depressing the release of C-fiber transmitters

Hyperpolarization of post-synaptic dorsal horn neurons

Page 37: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

The prolongation of the motor block of spinal anesthetics may result from the binding of α2-adrenergic agonists to motor neurons in the dorsal horn cells

Dose related sedation is by acting at locus ceruleus and also by promoting natural sleep pathways

Page 38: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

CONCLUSION

Dexmedetomidine as an adjuvant to intrathecal low dose Bupivacaine provides

Better quality of analgesia Delay in two segment regression Prolonged post op analgesia Better hemodynamic stability Good sedation without any side

effects

Page 39: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

REFERENCES

• Effects of adding dexmeditomedine to intrathecal bupivacaine in spinal anesthesia for gynecological procedures - American journal of applied sciences 6(5) : 882 – 887 , 2009

• Dexmedetomidine Enhances the Local Anesthetic Action of Lidocaine via an -2A Adrenoceptor - Anesth Analg 2008;107:96 –101

Page 40: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

• Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block Acta Anaesthesiologica Scandinavica - February 2006

• Effect of dexmedetomidine added to spinal bupivacaine for urological procedures – Saudi med journal 2009 ; vol 30 (3): 365- 370

Page 41: ADDING  DEXMEDETOMIDINE  TO  INTRATHECAL LOW DOSE BUPIVACAINE  IN  VAGINAL HYSTERECTOMY

THANK YOU